Restani, {RB }, Pires {RF }, Baptista {PV}, Fernandes {AR}, Casimiro T, Bonifácio {VDB }, Aguiar-Ricardo A.
2020.
Nano-in-Micro Sildenafil Dry Powder Formulations for the Treatment of Pulmonary Arterial Hypertension Disorders: The Synergic Effect of POxylated Polyurea Dendrimers, PLGA, and Cholesterol, jun. Particle and Particle Systems Characterization. 37, Number 6: Wiley-VCH Verlag
AbstractPOXylated polyurea dendrimer nanoparticles (PUREG4OOx48) are loaded with sildenafil (SDF) by a supercritical carbon dioxide–assisted (scCO2) impregnation. Further supercritical CO2-assisted spray drying (SASD) leads to hybrid nano-in-micro dry powder formulations that are investigated aiming at efficient pulmonary delivery of SDF in pulmonary arterial hypertension treatment. This is the first report of the production of poly(D,L-lactide-co-glycolide)-cholesterol (PLGA-Chol) microparticles processed by SASD. The optimized formulation of nano-in-microparticles is composed of PLGA, Chol, and PUREG4OOx48, loaded with SDF solutions in a 77:23 ratio (PLGA-Chol:dendrimer, w/w). The dry powders are fully characterized and found to be highly biodegradable and biocompatible, and the SDF release profile evaluates under different pH values. The median mass average diameter (MMAD) of the nano-in-micro systems varies between 2.57 and 5 µm and the fine particle fraction (FPF) between 36% and 29% for PUREG4OMeOx48[PLGA-Chol] and PUREG4OEtOx48[PLGA-Chol], respectively. The data validate the potential use of these new formulations in inhalation therapy. In vitro studies are also carried out in order to evaluate the effect of the free drug in cell viability and formulations cytotoxicity.
Oliveira, {BB }, Fernandes {AR}, Baptista {PV}.
2020.
Nanotheranostics in Gene Therapy, jan. Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine. :82–115., United Kingdom: Bentham Science Publishers
AbstractThe continuous advances in molecular genetics have prompt for a wealth of tools capable to modulate genome and the corresponding gene expression. These innovative technologies have broadened the range of possibilities for gene therapy, either to decrease expression of malignant genes and mutations or edition of genomes for correction of errors. These strategies rely on the delivery of therapeutic nucleic acids to cells and tissues that must overcome several biological barriers. Indeed, a key element for the success of any gene therapy formulation is the carrier agent capable to deliver the therapeutic nucleic acid moieties to a specific target and promote efficient cellular uptake, while preventing deleterious off-target effects and degradation by endogenous nucleases. The initial vectorization strategies proved to be rather immunogenic, limited in the amount of genetic material that can be packed and raised severe toxicity concerns. Nowadays, a new generation of nanotechnology-based gene delivery systems are making an impact on the way we use therapeutic nucleic acids. These nanovectorization platforms have been developed so as to show low immunogenicity, low toxicity, ease of assembly and scale-up with higher loading capacity. Some of these nanoscale systems have also allowed for controlled release system and for the simultaneous capability of monitorization of effect - nanotheranostics. Herein, we provide a review on the variety of gene delivery vectors and platforms at the nanoscale.
Machado, JF, Sequeira D, Marques F, Piedade MFM, Villa de Brito MJ, Helena Garcia M, Fernandes AR, Morais TS.
2020.
New copper(I) complexes selective for prostate cancer cells, 2020. Dalton Trans. 49(35):12273-12286.
AbstractA new family of eighteen Cu(i) complexes of the general formula [Cu(PP)(LL)][BF4], where PP is a phosphane ligand and LL represents an N,O-heteroaromatic bidentate ligand, has been synthesized and fully characterized by classical analytical and spectroscopic methods. Five complexes of this series were also characterized by single crystal X-ray diffraction studies. The cytotoxicity of all compounds was evaluated in breast (MCF7) and prostate (LNCap) human cancer cells and in a normal prostate cell line (RWPE). In general, all compounds showed higher cytotoxicity for the prostate cancer cells than for the breast cells, with IC50 values in the range 0.2-2 muM after 24 h of treatment. The most cytotoxic compound, [Cu(dppe)(2-ap)][BF4] (16), where dppe = 1,2-bis(diphenylphosphano) ethane and 2-ap = 2-acetylpyridine, showed a high level of cellular internalization, generation of intracellular ROS and activation of the cell death mechanism via apoptosis/necrosis. Owing to its high cytotoxic activity for LNCap cells, being 70-fold higher than that for normal prostate cells (RWPE), complex (16) was found to be the most promising for further research in prostate cancer models.
Zanatta, M, Simon NM, Dupont J.
2020.
The Nature of Carbon Dioxide in Bare Ionic Liquid. ChemSusChem. 13:3101-3109.
AbstractIonic liquids (ILs) are among the most studied and promising materials for selective CO2 capture and transformation. The high CO2 sorption capacity associated with the possibility to activate this rather stable molecule through stabilization of ionic/radical species or covalent interactions either with the cation or anion has opened new avenues for CO2 functionalization. However, recent reports have demonstrated that another simpler and plausible pathway is also involved in the sorption/activation of CO2 by ILs associated with basic anions. Bare ILs or IL solutions contain almost invariable significant amounts of water and through interaction with CO2 generate carbonates/bicarbonates rather than carbamic acids or amidates. In these cases, the IL acts as a base and not a nucleophile and yields buffer‐like solutions that can be used to shift the equilibrium toward acid products in different CO2 reutilization reactions. In this Minireview, the emergence of IL buffer‐like solutions as a new reactivity paradigm in CO2 capture and activation is described and analyzed critically, mainly through the evaluation of NMR data.